| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone H2AXS139 kinase activity | 6.42e-05 | 3 | 93 | 2 | GO:0035979 | |
| GeneOntologyMolecularFunction | histone H2AX kinase activity | 2.13e-04 | 5 | 93 | 2 | GO:0141003 | |
| GeneOntologyMolecularFunction | dolichyl-phosphate-mannose-protein mannosyltransferase activity | 5.90e-04 | 8 | 93 | 2 | GO:0004169 | |
| GeneOntologyBiologicalProcess | telomerase catalytic core complex assembly | 1.97e-05 | 2 | 92 | 2 | GO:1904868 | |
| GeneOntologyBiologicalProcess | positive regulation of telomerase catalytic core complex assembly | 1.97e-05 | 2 | 92 | 2 | GO:1904884 | |
| GeneOntologyBiologicalProcess | regulation of telomerase catalytic core complex assembly | 1.97e-05 | 2 | 92 | 2 | GO:1904882 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization to telomere | 5.89e-05 | 3 | 92 | 2 | GO:0097694 | |
| GeneOntologyBiologicalProcess | establishment of protein-containing complex localization to telomere | 5.89e-05 | 3 | 92 | 2 | GO:0097695 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | MRTFB PPP2R5D ERCC6 ZBTB7C ZNF827 MTF1 PPRC1 SREBF1 IRF3 CAMTA2 ATM TBR1 BCL9 MEIS2 MAF MEOX1 NPAT | 1.24e-04 | 1390 | 92 | 17 | GO:0045944 |
| GeneOntologyBiologicalProcess | neuron projection development | ERBB2 MRTFB PPP2R5D NRXN3 ERCC6 USP9X DAB1 ADGRB3 PRKCI PRKG1 RERE TBR1 ADNP PIP5K1C CDH4 OTOG | 1.65e-04 | 1285 | 92 | 16 | GO:0031175 |
| HumanPheno | Long philtrum | PPP2R5D ERCC6 RTL1 USP9X ANKRD11 FGD1 RERE ADNP SPEN MEIS2 MAF | 1.14e-05 | 429 | 29 | 11 | HP:0000343 |
| HumanPheno | Upper-limb joint contracture | 1.71e-05 | 362 | 29 | 10 | HP:0100360 | |
| HumanPheno | Joint contractures | 2.14e-05 | 292 | 29 | 9 | HP:0001372 | |
| HumanPheno | Joint contracture of the hand | 2.38e-05 | 296 | 29 | 9 | HP:0009473 | |
| HumanPheno | Flexion contracture of finger | 3.92e-05 | 240 | 29 | 8 | HP:0005651 | |
| HumanPheno | Camptodactyly (hands) | 3.92e-05 | 240 | 29 | 8 | HP:0010563 | |
| HumanPheno | Joint contractures involving the joints of the feet | 3.92e-05 | 240 | 29 | 8 | HP:0100492 | |
| HumanPheno | Camptodactyly of finger | 3.92e-05 | 240 | 29 | 8 | HP:0100490 | |
| HumanPheno | Interphalangeal joint contracture of finger | 3.92e-05 | 240 | 29 | 8 | HP:0001220 | |
| HumanPheno | Camptodactyly of toe | 3.92e-05 | 240 | 29 | 8 | HP:0001836 | |
| HumanPheno | Flexion contracture of toe | 3.92e-05 | 240 | 29 | 8 | HP:0005830 | |
| HumanPheno | Toe joint contracture | 4.04e-05 | 241 | 29 | 8 | HP:0034675 | |
| HumanPheno | High anterior hairline | 5.81e-05 | 76 | 29 | 5 | HP:0009890 | |
| HumanPheno | Flexion contracture of finger | 6.40e-05 | 257 | 29 | 8 | HP:0012785 | |
| HumanPheno | Finger joint contracture | 6.76e-05 | 259 | 29 | 8 | HP:0034681 | |
| HumanPheno | Abnormal phalangeal joint morphology of the hand | 7.34e-05 | 262 | 29 | 8 | HP:0006261 | |
| HumanPheno | Camptodactyly | 8.22e-05 | 346 | 29 | 9 | HP:0012385 | |
| HumanPheno | Flexion contracture of digit | 1.17e-04 | 362 | 29 | 9 | HP:0030044 | |
| HumanPheno | Abnormal toe morphology | PPP2R5D ERCC6 ATR DSP RTL1 USP9X FGD1 PRKG1 RERE TBR1 ADNP SPEN PLEKHG5 MEIS2 | 1.33e-04 | 893 | 29 | 14 | HP:0001780 |
| HumanPheno | Abnormal cardiac ventricle morphology | PPP2R5D DSP RTL1 SREBF1 ANKRD11 TMPO ATM PRKG1 RERE SPEN MEIS2 ZNF687 MEOX1 | 1.44e-04 | 780 | 29 | 13 | HP:0001713 |
| HumanPheno | Limb joint contracture | 1.59e-04 | 469 | 29 | 10 | HP:0003121 | |
| HumanPheno | Abnormal size of the palpebral fissures | 1.82e-04 | 298 | 29 | 8 | HP:0200007 | |
| HumanPheno | Orofacial cleft | PPP2R5D ATR DSP RTL1 USP9X ANKRD11 FGD1 RERE TBR1 MEIS2 MAF MEOX1 | 2.09e-04 | 694 | 29 | 12 | HP:0000202 |
| HumanPheno | Craniofacial cleft | PPP2R5D ATR DSP RTL1 USP9X ANKRD11 FGD1 RERE TBR1 MEIS2 MAF MEOX1 | 2.09e-04 | 694 | 29 | 12 | HP:5201015 |
| HumanPheno | Flexion contracture | PPP2R5D ERCC6 ATR DSP RTL1 FGD1 ATM RERE TBR1 PIP5K1C SPEN PLEKHG5 MAF | 2.33e-04 | 817 | 29 | 13 | HP:0001371 |
| HumanPheno | Abnormal palate morphology | PPP2R5D FRMPD4 ATR DSP RTL1 USP9X ANKRD11 FGD1 PRKG1 RERE TBR1 ADNP SPEN MEIS2 MAF MEOX1 | 2.35e-04 | 1202 | 29 | 16 | HP:0000174 |
| HumanPheno | Abnormality of upper limb joint | PPP2R5D ERCC6 ATR DSP RTL1 FGD1 RERE TBR1 SPEN PLEKHG5 MAF MEOX1 | 2.44e-04 | 705 | 29 | 12 | HP:0009810 |
| HumanPheno | Downslanted palpebral fissures | 2.58e-04 | 497 | 29 | 10 | HP:0000494 | |
| HumanPheno | Abnormal joint physiology | PPP2R5D ERCC6 ATR DSP RTL1 USP9X ANKRD11 FGD1 ATM RERE TBR1 ADNP PIP5K1C SPEN PLEKHG5 MAF MEOX1 | 2.73e-04 | 1358 | 29 | 17 | HP:0034430 |
| HumanPheno | Abnormality of joint mobility | PPP2R5D ERCC6 ATR DSP RTL1 USP9X ANKRD11 FGD1 ATM RERE TBR1 ADNP PIP5K1C SPEN PLEKHG5 MAF MEOX1 | 2.73e-04 | 1358 | 29 | 17 | HP:0011729 |
| HumanPheno | Abnormality of the chin | 2.98e-04 | 409 | 29 | 9 | HP:0000306 | |
| HumanPheno | 3-4 finger osseus syndactyly | 3.10e-04 | 5 | 29 | 2 | HP:0006097 | |
| HumanPheno | Joint contracture | PPP2R5D ERCC6 ATR DSP RTL1 FGD1 ATM RERE TBR1 PIP5K1C SPEN PLEKHG5 MAF | 3.21e-04 | 843 | 29 | 13 | HP:0034392 |
| HumanPheno | Abnormality of the philtrum | PPP2R5D ERCC6 RTL1 USP9X ANKRD11 FGD1 RERE TBR1 ADNP SPEN MEIS2 MAF | 3.23e-04 | 726 | 29 | 12 | HP:0000288 |
| HumanPheno | Congenital abnormal hair pattern | 3.45e-04 | 327 | 29 | 8 | HP:0011361 | |
| HumanPheno | Abnormal finger morphology | ERBB2 PPP2R5D ERCC6 ATR DSP RTL1 USP9X SREBF1 ANKRD11 FGD1 PRKG1 RERE TBR1 ADNP SPEN MEIS2 MAF | 3.53e-04 | 1385 | 29 | 17 | HP:0001167 |
| HumanPheno | Abnormal finger phalanx morphology | PPP2R5D ERCC6 ATR DSP RTL1 USP9X FGD1 RERE TBR1 ADNP SPEN MEIS2 | 3.78e-04 | 738 | 29 | 12 | HP:0005918 |
| HumanPheno | Abnormal stomach morphology | ERBB2 PPP2R5D ERCC6 CD19 DSP RTL1 USP9X ATM RERE ADNP SPEN MEIS2 | 3.97e-04 | 742 | 29 | 12 | HP:0002577 |
| HumanPheno | Foot joint contracture | 3.98e-04 | 334 | 29 | 8 | HP:0008366 | |
| HumanPheno | Brachycephaly | 4.17e-04 | 253 | 29 | 7 | HP:0000248 | |
| HumanPheno | Scoliosis | PPP2R5D ERCC6 ATR RTL1 USP9X ANKRD11 FGD1 PRKG1 RERE ADNP SPEN PLEKHG5 MEIS2 MAF MEOX1 | 4.18e-04 | 1122 | 29 | 15 | HP:0002650 |
| HumanPheno | Abnormality of the scalp hair | 4.56e-04 | 433 | 29 | 9 | HP:0100037 | |
| HumanPheno | Osseous finger syndactyly | 4.63e-04 | 6 | 29 | 2 | HP:0010492 | |
| HumanPheno | Abnormal tendon morphology | PPP2R5D ERCC6 ATR DSP RTL1 FGD1 ATM RERE TBR1 PIP5K1C SPEN PLEKHG5 MAF | 4.69e-04 | 875 | 29 | 13 | HP:0100261 |
| HumanPheno | Cleft palate | PPP2R5D ATR DSP RTL1 USP9X ANKRD11 FGD1 TBR1 MEIS2 MAF MEOX1 | 4.79e-04 | 643 | 29 | 11 | HP:0000175 |
| HumanPheno | Abnormality of the palpebral fissures | PPP2R5D ERCC6 ATR RTL1 USP9X ANKRD11 FGD1 RERE TBR1 ADNP SPEN MEIS2 MAF | 4.97e-04 | 880 | 29 | 13 | HP:0008050 |
| HumanPheno | Smooth philtrum | 5.00e-04 | 185 | 29 | 6 | HP:0000319 | |
| HumanPheno | Abnormal hard palate morphology | PPP2R5D ATR DSP RTL1 USP9X ANKRD11 FGD1 TBR1 MEIS2 MAF MEOX1 | 5.05e-04 | 647 | 29 | 11 | HP:0100737 |
| HumanPheno | Abnormal breast morphology | 5.23e-04 | 441 | 29 | 9 | HP:0031093 | |
| HumanPheno | Abnormality of the breast | 5.78e-04 | 447 | 29 | 9 | HP:0000769 | |
| HumanPheno | Abnormal scalp morphology | 6.07e-04 | 450 | 29 | 9 | HP:0001965 | |
| HumanPheno | Abnormal pinna morphology | PPP2R5D ERCC6 FRMPD4 ATR DSP RTL1 USP9X ANKRD11 FGD1 RERE TBR1 ADNP SPEN MEIS2 MAF MEOX1 | 6.09e-04 | 1299 | 29 | 16 | HP:0000377 |
| HumanPheno | Finger clinodactyly | 6.28e-04 | 452 | 29 | 9 | HP:0040019 | |
| HumanPheno | Abnormal hair pattern | ERCC6 FRMPD4 RTL1 USP9X ANKRD11 FGD1 RERE ADNP SPEN MEIS2 MEOX1 | 7.40e-04 | 676 | 29 | 11 | HP:0010720 |
| HumanPheno | Posteriorly rotated ears | 8.36e-04 | 470 | 29 | 9 | HP:0000358 | |
| HumanPheno | Congenital muscular torticollis | 8.58e-04 | 8 | 29 | 2 | HP:0005988 | |
| HumanPheno | Abnormality of the outer ear | PPP2R5D ERCC6 FRMPD4 ATR DSP RTL1 USP9X ANKRD11 FGD1 RERE TBR1 ADNP SPEN MEIS2 MAF MEOX1 | 8.60e-04 | 1337 | 29 | 16 | HP:0000356 |
| HumanPheno | Abnormality of hair texture | 9.50e-04 | 290 | 29 | 7 | HP:0010719 | |
| HumanPheno | Pointed chin | 9.54e-04 | 138 | 29 | 5 | HP:0000307 | |
| HumanPheno | Abnormality of the hairline | 1.03e-03 | 294 | 29 | 7 | HP:0009553 | |
| HumanPheno | Abnormal curvature of the vertebral column | PPP2R5D ERCC6 ATR RTL1 USP9X ANKRD11 FGD1 PRKG1 RERE ADNP SPEN PLEKHG5 MEIS2 MAF MEOX1 | 1.07e-03 | 1219 | 29 | 15 | HP:0010674 |
| HumanPheno | Ivory epiphyses | 1.10e-03 | 9 | 29 | 2 | HP:0010583 | |
| HumanPheno | Single transverse palmar crease | 1.11e-03 | 215 | 29 | 6 | HP:0000954 | |
| HumanPheno | Abnormality of the frontal hairline | 1.11e-03 | 215 | 29 | 6 | HP:0000599 | |
| HumanPheno | Broad phalanx | 1.31e-03 | 148 | 29 | 5 | HP:0006009 | |
| HumanPheno | Broad phalanges of the hand | 1.31e-03 | 148 | 29 | 5 | HP:0009768 | |
| HumanPheno | Facial asymmetry | 1.35e-03 | 149 | 29 | 5 | HP:0000324 | |
| HumanPheno | Lower-limb joint contracture | 1.39e-03 | 403 | 29 | 8 | HP:0005750 | |
| HumanPheno | Abnormal upper lip morphology | PPP2R5D ERCC6 RTL1 USP9X ANKRD11 FGD1 RERE TBR1 ADNP SPEN MEIS2 MAF MEOX1 | 1.44e-03 | 980 | 29 | 13 | HP:0000177 |
| HumanPheno | Wide nasal bridge | 1.47e-03 | 508 | 29 | 9 | HP:0000431 | |
| HumanPheno | Abnormal 5th finger morphology | 1.49e-03 | 509 | 29 | 9 | HP:0004207 | |
| HumanPheno | Abnormal thumb morphology | 1.51e-03 | 408 | 29 | 8 | HP:0001172 | |
| HumanPheno | Short foot | 1.52e-03 | 153 | 29 | 5 | HP:0001773 | |
| HumanPheno | Short feet | 1.52e-03 | 153 | 29 | 5 | HP:0001766 | |
| HumanPheno | Small feet | 1.52e-03 | 153 | 29 | 5 | HP:0001764 | |
| HumanPheno | Broad thumb | 1.54e-03 | 90 | 29 | 4 | HP:0011304 | |
| HumanPheno | Broad finger | 1.56e-03 | 154 | 29 | 5 | HP:0001500 | |
| HumanPheno | Slanting of the palpebral fissure | PPP2R5D ATR USP9X ANKRD11 FGD1 RERE TBR1 ADNP SPEN MEIS2 MAF | 1.58e-03 | 739 | 29 | 11 | HP:0200006 |
| HumanPheno | Abnormal nail morphology | 1.64e-03 | 516 | 29 | 9 | HP:0001597 | |
| HumanPheno | Abnormal vertebral segmentation and fusion | 1.67e-03 | 11 | 29 | 2 | HP:0005640 | |
| HumanPheno | Neuroepithelial neoplasm | 1.67e-03 | 92 | 29 | 4 | HP:0030063 | |
| HumanPheno | Broad long bones | 1.70e-03 | 157 | 29 | 5 | HP:0005622 | |
| HumanPheno | Abnormal hair morphology | ERCC6 FRMPD4 ATR DSP RTL1 USP9X SREBF1 ANKRD11 FGD1 ATM RERE ADNP SPEN MEIS2 MAF MEOX1 | 1.80e-03 | 1424 | 29 | 16 | HP:0001595 |
| HumanPheno | Neuroectodermal neoplasm | 1.81e-03 | 94 | 29 | 4 | HP:0030061 | |
| HumanPheno | Nervous tissue neoplasm | 1.81e-03 | 94 | 29 | 4 | HP:0030060 | |
| HumanPheno | Clinodactyly of the 5th finger | 1.82e-03 | 420 | 29 | 8 | HP:0004209 | |
| HumanPheno | Clinodactyly of hands | 1.85e-03 | 421 | 29 | 8 | HP:0001157 | |
| HumanPheno | Deviation of the 5th finger | 1.85e-03 | 421 | 29 | 8 | HP:0009179 | |
| HumanPheno | Telangiectasia | 1.90e-03 | 161 | 29 | 5 | HP:0001009 | |
| HumanPheno | Sandal gap | 1.96e-03 | 96 | 29 | 4 | HP:0001852 | |
| Domain | MAGEA3/MAGEA6 | 2.25e-05 | 2 | 89 | 2 | IPR030097 | |
| Domain | MAGE_N | 1.12e-04 | 20 | 89 | 3 | SM01392 | |
| Domain | DUF1736 | 1.34e-04 | 4 | 89 | 2 | IPR013618 | |
| Domain | DUF1736 | 1.34e-04 | 4 | 89 | 2 | PF08409 | |
| Domain | MAGE_N | 1.51e-04 | 22 | 89 | 3 | PF12440 | |
| Domain | MAGE_N | 1.51e-04 | 22 | 89 | 3 | IPR021072 | |
| Domain | DDE_Tnp_1_7 | 2.22e-04 | 5 | 89 | 2 | PF13843 | |
| Domain | FATC | 2.22e-04 | 5 | 89 | 2 | PF02260 | |
| Domain | PGBD | 2.22e-04 | 5 | 89 | 2 | IPR029526 | |
| Domain | FAT | 3.33e-04 | 6 | 89 | 2 | PS51189 | |
| Domain | FATC | 3.33e-04 | 6 | 89 | 2 | PS51190 | |
| Domain | FAT | 3.33e-04 | 6 | 89 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 3.33e-04 | 6 | 89 | 2 | IPR003151 | |
| Domain | FATC_dom | 3.33e-04 | 6 | 89 | 2 | IPR003152 | |
| Domain | PIK_FAT | 3.33e-04 | 6 | 89 | 2 | IPR014009 | |
| Domain | FATC | 3.33e-04 | 6 | 89 | 2 | SM01343 | |
| Domain | MAGE | 5.62e-04 | 34 | 89 | 3 | SM01373 | |
| Domain | MAGE | 6.67e-04 | 36 | 89 | 3 | PS50838 | |
| Domain | MAGE | 6.67e-04 | 36 | 89 | 3 | PF01454 | |
| Domain | MHD_dom | 6.67e-04 | 36 | 89 | 3 | IPR002190 | |
| Domain | PI3/4_kinase_CS | 2.26e-03 | 15 | 89 | 2 | IPR018936 | |
| Domain | - | 2.58e-03 | 16 | 89 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 2.58e-03 | 16 | 89 | 2 | SM00146 | |
| Domain | PI3/4_kinase_cat_dom | 3.27e-03 | 18 | 89 | 2 | IPR000403 | |
| Domain | PI3_PI4_kinase | 3.27e-03 | 18 | 89 | 2 | PF00454 | |
| Domain | PI3_4_KINASE_3 | 3.27e-03 | 18 | 89 | 2 | PS50290 | |
| Domain | PI3_4_KINASE_1 | 3.27e-03 | 18 | 89 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 3.27e-03 | 18 | 89 | 2 | PS00916 | |
| Domain | PH_dom-like | 4.23e-03 | 426 | 89 | 7 | IPR011993 | |
| Domain | tRNA-bd_arm | 5.79e-03 | 24 | 89 | 2 | IPR010978 | |
| Domain | PID | 7.83e-03 | 28 | 89 | 2 | PF00640 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | CDCA2 ZHX3 RAD51AP1 WIZ DSP ATAD5 AHNAK GTSE1 MARF1 ANKRD11 TMPO ICE1 ADNP SPEN HDGFL2 NPAT | 5.64e-09 | 954 | 94 | 16 | 36373674 |
| Pubmed | LRIG3 AGAP5 ERBB2 NRXN3 NUAK1 ADGRB3 TMEM131L AKAP11 ICE1 ADNP PLEKHG5 ZNF687 | 2.09e-08 | 529 | 94 | 12 | 14621295 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SCAF1 ERBB2 WIZ NUAK1 ZNF827 PPRC1 AHNAK GTSE1 SREBF1 ANKRD11 ICE1 BCL9 PIP5K1C SPEN PLEKHG5 ZNF687 | 4.35e-08 | 1105 | 94 | 16 | 35748872 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SCAF1 ZHX3 SEC16B ATR DSP GTSE1 TMPO ATM RERE BCL9 PNISR SPEN ZNF687 | 1.71e-07 | 774 | 94 | 13 | 15302935 |
| Pubmed | 1.90e-07 | 5 | 94 | 3 | 8037761 | ||
| Pubmed | 2.08e-07 | 418 | 94 | 10 | 34709266 | ||
| Pubmed | CDCA2 ZHX3 CNOT11 WIZ ATAD5 USP9X MARF1 IRF3 RERE TBR1 BCL9 ADNP SPEN PACSIN2 SNTB2 ZNF687 NPAT | 2.60e-07 | 1429 | 94 | 17 | 35140242 | |
| Pubmed | Expression of melanoma-associated antigens in oral squamous cell carcinoma. | 6.64e-07 | 7 | 94 | 3 | 18197853 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | CDCA2 ZHX3 RAD51AP1 ERCC6 WIZ ATAD5 TMPO ADNP SPEN HDGFL2 NPAT | 7.93e-07 | 608 | 94 | 11 | 36089195 |
| Pubmed | MAGE cancer-testis antigens protect the mammalian germline under environmental stress. | 1.06e-06 | 8 | 94 | 3 | 31149633 | |
| Pubmed | The Magea gene cluster regulates male germ cell apoptosis without affecting the fertility in mice. | 1.06e-06 | 8 | 94 | 3 | 27226137 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | CDCA2 SCAF1 WIZ ATR DSP ATAD5 AHNAK SREBF1 ANKRD11 TMPO ADNP PNISR SPEN HDGFL2 ZNF687 | 1.97e-06 | 1294 | 94 | 15 | 30804502 |
| Pubmed | SCAF1 CNOT11 MRTFB ERCC6 WIZ APPL2 BMP2K ATAD5 ANKRD11 OS9 ICE1 PNISR SPEN HDGFL2 SNTB2 ZNF687 | 2.47e-06 | 1497 | 94 | 16 | 31527615 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 2.61e-06 | 430 | 94 | 9 | 35044719 | |
| Pubmed | Aging and chronic DNA damage response activate a regulatory pathway involving miR-29 and p53. | 4.13e-06 | 12 | 94 | 3 | 21522133 | |
| Pubmed | CAMK2D serves as a molecular scaffold for RNF8-MAD2 complex to induce mitotic checkpoint in glioma. | 5.88e-06 | 94 | 94 | 5 | 37468549 | |
| Pubmed | Genes expressed in Atoh1 neuronal lineages arising from the r1/isthmus rhombic lip. | 6.19e-06 | 95 | 94 | 5 | 21440680 | |
| Pubmed | The melanoma antigen gene (MAGE) family is clustered in the chromosomal band Xq28. | 6.81e-06 | 14 | 94 | 3 | 8575766 | |
| Pubmed | Single-stranded DNA orchestrates an ATM-to-ATR switch at DNA breaks. | 7.23e-06 | 2 | 94 | 2 | 19285939 | |
| Pubmed | Expression variations of DNA damage response genes ATM and ATR in blood cancer patients. | 7.23e-06 | 2 | 94 | 2 | 37338595 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 28851706 | ||
| Pubmed | Quantitative phosphoproteomics reveals mitotic function of the ATR activator ETAA1. | 7.23e-06 | 2 | 94 | 2 | 30755469 | |
| Pubmed | Mutations revealed by sequencing the 5' half of the gene for ataxia telangiectasia. | 7.23e-06 | 2 | 94 | 2 | 8789452 | |
| Pubmed | Novel insights into the mechanism of cell cycle kinases Mec1(ATR) and Tel1(ATM). | 7.23e-06 | 2 | 94 | 2 | 34151669 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 30056111 | ||
| Pubmed | Inhibition of Atm and/or Atr disrupts gene silencing on the inactive X chromosome. | 7.23e-06 | 2 | 94 | 2 | 16213462 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 27442013 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 24726882 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 26061708 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 9199932 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 20103595 | ||
| Pubmed | Interplay between ATM and ATR in the regulation of common fragile site stability. | 7.23e-06 | 2 | 94 | 2 | 17934520 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 25483091 | ||
| Pubmed | ATM and ATR activities maintain replication fork integrity during SV40 chromatin replication. | 7.23e-06 | 2 | 94 | 2 | 23592994 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 19527713 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 26567218 | ||
| Pubmed | RPA-Binding Protein ETAA1 Is an ATR Activator Involved in DNA Replication Stress Response. | 7.23e-06 | 2 | 94 | 2 | 27818175 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 33742106 | ||
| Pubmed | Roles of ATM and ATR in DNA double strand breaks and replication stress. | 7.23e-06 | 2 | 94 | 2 | 33887296 | |
| Pubmed | ATR disruption leads to chromosomal fragmentation and early embryonic lethality. | 7.23e-06 | 2 | 94 | 2 | 10691732 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 31114877 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 35011623 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 26517239 | ||
| Pubmed | DNA damage-sensing kinases mediate the mouse 2-cell embryo's response to genotoxic stress. | 7.23e-06 | 2 | 94 | 2 | 21593482 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 25232030 | ||
| Pubmed | ATM acts downstream of ATR in the DNA damage response signaling of bystander cells. | 7.23e-06 | 2 | 94 | 2 | 18757420 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 11927575 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 28820634 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 29279380 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 12526805 | ||
| Pubmed | Interaction between HER2 and ATM predicts poor survival in bladder cancer patients. | 7.23e-06 | 2 | 94 | 2 | 36056635 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 24238855 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 16474843 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 8843195 | ||
| Pubmed | Viral DNA replication-dependent DNA damage response activation during BK polyomavirus infection. | 7.23e-06 | 2 | 94 | 2 | 25694603 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 26124337 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 25812484 | ||
| Pubmed | Roles of ATM and ATR-mediated DNA damage responses during lytic BK polyomavirus infection. | 7.23e-06 | 2 | 94 | 2 | 22952448 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 22707303 | ||
| Pubmed | ATM regulates ATR chromatin loading in response to DNA double-strand breaks. | 7.23e-06 | 2 | 94 | 2 | 16461339 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 23297361 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 23272087 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 27129217 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 12975478 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 20368801 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 30746633 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 33640756 | ||
| Pubmed | A role for ATR in the DNA damage-induced phosphorylation of p53. | 7.23e-06 | 2 | 94 | 2 | 9925639 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 21908846 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 29263259 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 23382809 | ||
| Pubmed | An S/T-Q cluster domain census unveils new putative targets under Tel1/Mec1 control. | 7.23e-06 | 2 | 94 | 2 | 23176708 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 26743489 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 15533933 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 17124492 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 25564441 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 12519769 | ||
| Pubmed | Identification of a novel protein kinase mediating Akt survival signaling to the ATM protein. | 7.23e-06 | 2 | 94 | 2 | 12409306 | |
| Pubmed | The association of ATR protein with mouse meiotic chromosome cores. | 7.23e-06 | 2 | 94 | 2 | 10382071 | |
| Pubmed | Structure, chromosomal localization, and expression of 12 genes of the MAGE family. | 8.50e-06 | 15 | 94 | 3 | 7927540 | |
| Pubmed | Cdk12 Regulates Neurogenesis and Late-Arising Neuronal Migration in the Developing Cerebral Cortex. | 8.50e-06 | 15 | 94 | 3 | 27073218 | |
| Pubmed | 1.01e-05 | 105 | 94 | 5 | 9628581 | ||
| Pubmed | DNA-PKcs, ATM, and ATR Interplay Maintains Genome Integrity during Neurogenesis. | 1.04e-05 | 16 | 94 | 3 | 28123024 | |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 1.40e-05 | 289 | 94 | 7 | 23752268 | |
| Pubmed | 1.51e-05 | 18 | 94 | 3 | 28620865 | ||
| Pubmed | 1.52e-05 | 407 | 94 | 8 | 12693553 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 1.90e-05 | 202 | 94 | 6 | 33005030 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CDCA2 EHBP1 ERBB2 DSP AHNAK GTSE1 ANKRD11 AKAP11 PRKCI DOP1A OTOG | 2.14e-05 | 861 | 94 | 11 | 36931259 |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 26563132 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 25846551 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 23438602 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 18344416 | ||
| Pubmed | Inhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent wortmannin. | 2.16e-05 | 3 | 94 | 2 | 9766667 | |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 27625305 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 18451257 | ||
| Pubmed | A subset of ATM- and ATR-dependent phosphorylation events requires the BRCA1 protein. | 2.16e-05 | 3 | 94 | 2 | 12773400 | |
| Pubmed | DNA Damage Signaling Is Required for Replication of Human Bocavirus 1 DNA in Dividing HEK293 Cells. | 2.16e-05 | 3 | 94 | 2 | 27733644 | |
| Pubmed | Regulation of HER2 oncogene transcription by a multifunctional coactivator/corepressor complex. | 2.16e-05 | 3 | 94 | 2 | 24678732 | |
| Pubmed | Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. | 2.16e-05 | 3 | 94 | 2 | 11114888 | |
| Pubmed | Effect of ATM, CHEK2 and ERBB2 TAGSNPs and haplotypes on endometrial cancer risk. | 2.16e-05 | 3 | 94 | 2 | 17164260 | |
| Interaction | HDAC1 interactions | EHBP1 MAGEA3 ZHX3 MRTFB ERCC6 WIZ ATR ZNF827 AHNAK SREBF1 ATM PRKG1 RERE ADNP SPEN ZNF687 NPAT | 1.11e-05 | 1108 | 93 | 17 | int:HDAC1 |
| Interaction | SMC5 interactions | CDCA2 ZHX3 RAD51AP1 WIZ DSP ATAD5 AHNAK GTSE1 MARF1 ANKRD11 TMPO ICE1 ADNP SPEN HDGFL2 NPAT | 1.25e-05 | 1000 | 93 | 16 | int:SMC5 |
| Interaction | CHD4 interactions | MAGEA3 ERCC6 WIZ ATR ZNF827 DSP MTF1 AHNAK TMPO PRKCI ATM ADNP SPEN HDGFL2 ZNF687 | 2.43e-05 | 938 | 93 | 15 | int:CHD4 |
| Cytoband | 11q22-q23 | 6.19e-05 | 6 | 94 | 2 | 11q22-q23 | |
| Cytoband | 19q13.3-q13.4 | 3.19e-04 | 13 | 94 | 2 | 19q13.3-q13.4 | |
| GeneFamily | MAGE family | 2.06e-04 | 40 | 52 | 3 | 1136 | |
| GeneFamily | WD repeat domain containing|Protein phosphatase 2 regulatory subunits | 8.32e-04 | 15 | 52 | 2 | 696 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 8.32e-04 | 15 | 52 | 2 | 529 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 1.07e-03 | 17 | 52 | 2 | 1291 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.89e-03 | 206 | 52 | 4 | 682 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 3.13e-03 | 29 | 52 | 2 | 396 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | EHBP1 ZHX3 PPP2R3A ATR NUAK1 BMP2K USP9X TMEM131L AKAP11 PRKCI ADNP PNISR SPEN MEIS2 NPAT | 3.82e-07 | 856 | 94 | 15 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | EHBP1 ZHX3 PPP2R3A ATR NUAK1 USP9X MARF1 PRKCI PNISR SPEN MEIS2 | 9.14e-07 | 466 | 94 | 11 | M13522 |
| Coexpression | GSE3039_ALPHABETA_CD8_TCELL_VS_B1_BCELL_UP | 7.92e-06 | 200 | 94 | 7 | M6447 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 1.27e-05 | 300 | 94 | 8 | M8702 | |
| Coexpression | IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN | 4.24e-05 | 107 | 94 | 5 | M4913 | |
| Coexpression | FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_UP | 4.92e-05 | 587 | 94 | 10 | M40869 | |
| Coexpression | GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_DN | 7.42e-05 | 195 | 94 | 6 | M7410 | |
| Coexpression | HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP | 7.51e-05 | 23 | 94 | 3 | M1184 | |
| Coexpression | GENTILE_UV_LOW_DOSE_DN | 8.36e-05 | 64 | 94 | 4 | M4594 | |
| Coexpression | HADDAD_B_LYMPHOCYTE_PROGENITOR | 8.50e-05 | 290 | 94 | 7 | M939 | |
| Coexpression | GSE20715_WT_VS_TLR4_KO_6H_OZONE_LUNG_DN | 8.54e-05 | 200 | 94 | 6 | M4352 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_PROLIFERATING_SCHWANN_CELL | CDCA2 RAD51AP1 ERBB2 NRXN3 BMP2K SYNM TMEM245 GTSE1 SREBF1 IRF3 AKAP11 MAF NPAT | 9.82e-05 | 1054 | 94 | 13 | M45798 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_2_CELL | 1.05e-04 | 300 | 94 | 7 | M45675 | |
| Coexpression | VERNELL_RETINOBLASTOMA_PATHWAY_UP | 1.12e-04 | 69 | 94 | 4 | M15969 | |
| Coexpression | VERRECCHIA_RESPONSE_TO_TGFB1_C6 | 1.26e-04 | 5 | 94 | 2 | M15374 | |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 1.47e-04 | 221 | 94 | 6 | M39222 | |
| Coexpression | ZWANG_DOWN_BY_2ND_EGF_PULSE | 1.59e-04 | 321 | 94 | 7 | M2615 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.54e-08 | 170 | 94 | 7 | 99dd734c0972a40d5381e8e2d96bdaa31f6d06e6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.54e-08 | 170 | 94 | 7 | 3a14eeae221b8bb0bd0dadcb8e7a603431240a1e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.54e-08 | 170 | 94 | 7 | cdb6fad277f284c3fd5a6f45672a8edc24715882 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_bronchial_vessel-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.29e-06 | 163 | 94 | 6 | ba7d02db0f0e2f9916ec8db52c067c87b6917c23 | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.22e-06 | 179 | 94 | 6 | 111b1084f73306bdeffaaf240e7dbb4f5bf33de1 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.45e-06 | 182 | 94 | 6 | 3cbeaf7904a76c32137a00abb20e302d3d3c8bb8 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.45e-06 | 182 | 94 | 6 | ebc812ed3f25839ea25f76b952c463d79a8325b1 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.45e-06 | 182 | 94 | 6 | 47ff6b4002a4167412c79210651316d1342503f9 | |
| ToppCell | COVID-19-Heart-EC_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.52e-06 | 183 | 94 | 6 | ff95382cfed592190d0636d2b750328471f82e0d | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.52e-06 | 183 | 94 | 6 | fc9a7ba148c22d0c8a46f6bc56c772929ac496f7 | |
| ToppCell | 368C-Myeloid-Dendritic-cDC_proliferating_1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 2.77e-06 | 186 | 94 | 6 | 5cadab3271fce9ab6da3d7ba9827b8a221cac166 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.86e-06 | 187 | 94 | 6 | ec4b694487cc446999c7b27b119950a4f252c4b3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.86e-06 | 187 | 94 | 6 | 530e4e6d91b5c0d9aa4543caa2b734a1674c5788 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.13e-06 | 190 | 94 | 6 | 656483751e4bf137e4e4bfb2a03a478a8f7fcb63 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.33e-06 | 192 | 94 | 6 | 1ee4783051ec94ea94600f040edcb385fc4289f1 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.33e-06 | 192 | 94 | 6 | b016e229300c183e14c0e2bba494bf49c7899112 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.33e-06 | 192 | 94 | 6 | bfab13793e54de2550ee171397f7ece0625cdb4a | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.33e-06 | 192 | 94 | 6 | ac96831492c62ad9e1f7d0b764fbdf7d8a189ad9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.33e-06 | 192 | 94 | 6 | b54b0d5b88139905521c8d5d58332e89c08d589c | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.43e-06 | 193 | 94 | 6 | b835d28de9daeec5213172c96f62b332cda53bb5 | |
| ToppCell | droplet-Fat-Mat-18m-Endothelial-Cd36+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.53e-06 | 194 | 94 | 6 | 74d0eaa76f6d9af14110dfe5b4bf9751b99ff6e3 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Endothelial-blood_vessel_EC|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.75e-06 | 196 | 94 | 6 | a0ba408b802fa6d6e42e6d234b6879fdb1583f81 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-B-Large_pre-B|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.86e-06 | 197 | 94 | 6 | cebf47d66f425c84d3fea962e11f5bf4bfe2e60f | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.86e-06 | 197 | 94 | 6 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | ASK428-Endothelial|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.97e-06 | 198 | 94 | 6 | d69d0ff115298596173a4278897a65007a71f5df | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 3.97e-06 | 198 | 94 | 6 | b8bd1ba268480f54451648e01631b615a3401144 | |
| ToppCell | ILEUM-non-inflamed-(7)_ACKR1+_endothelial_cells|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.97e-06 | 198 | 94 | 6 | f8a6a75c9f2fbe32a22b14b6a029411c73c09f68 | |
| ToppCell | PSB|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.97e-06 | 198 | 94 | 6 | 4e6b0d1abc55d7a0d89bd7ecf0f13dc5bed66626 | |
| ToppCell | (5)_Dendritic_cell-(52)_cycling_DCs|(5)_Dendritic_cell / shred on Cell_type and subtype | 4.09e-06 | 199 | 94 | 6 | d0ff446a197062b10f37b585f3f8716d6d89e5b7 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.09e-06 | 199 | 94 | 6 | 98575fcce726589e93fbb4df1aab03e57cb56076 | |
| ToppCell | cellseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.21e-06 | 200 | 94 | 6 | a1f5684fe3815642159dd201b7ecc39f09bee1e8 | |
| ToppCell | Sigmoid-Dendritic_cell-cycling_DCs|Dendritic_cell / Region, Cell class and subclass | 4.21e-06 | 200 | 94 | 6 | 372fe9018481a4e9ac6ab3af43705a48238c4376 | |
| ToppCell | Biopsy_IPF-Immune-Proliferating_T_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 4.21e-06 | 200 | 94 | 6 | c43d1a83b2a8ad060f3d80c9438da8b7a5e307fb | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.64e-06 | 131 | 94 | 5 | a3a086ce6e69707ca6a042f3b15c130f81909acb | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-05 | 155 | 94 | 5 | babcb9e548f04ace8157d506d27c5941c692c491 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_bronchial_vessel|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.48e-05 | 163 | 94 | 5 | 977a970b1296234c22178420294cea73506ee02f | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l15|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.63e-05 | 165 | 94 | 5 | 94a5211072464fc24592bb107a853ce832e816fe | |
| ToppCell | Endothelial-endothelial_cell_of_bronchial_vessel|World / Lineage, Cell type, age group and donor | 2.63e-05 | 165 | 94 | 5 | 84e553d699ac56df89a77248f7308b9133e1b683 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.71e-05 | 166 | 94 | 5 | 9d4b44eb56ad38c26aed73444edf389abca6bdf6 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.87e-05 | 168 | 94 | 5 | 2fb2d916eb5000a637240d38e47a9b4f61f9f83f | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|LV / Chamber and Cluster_Paper | 3.12e-05 | 171 | 94 | 5 | e99ecae66530d1ae09330cee408c8f3950b87e67 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.21e-05 | 172 | 94 | 5 | 8d20eda599abf1e9e3e3b90f314acddee6a465a4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.49e-05 | 175 | 94 | 5 | d52794426f2703a80e91ae0a8ff2d8e0ce4aa4a8 | |
| ToppCell | 367C-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.49e-05 | 175 | 94 | 5 | 0b1aaa028ba844d4bcb4509fdab8bee648373935 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.49e-05 | 175 | 94 | 5 | 454f03e6109d65f5db08dbb41ecc19ffb6bbc4e0 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.68e-05 | 177 | 94 | 5 | 844017225e9039d1bc621a9630a30c2e9a51b36d | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.68e-05 | 177 | 94 | 5 | 26c25d10aa511b64cc7db43a8deea7b5d31bca96 | |
| ToppCell | IIH-CD8-antiviral_CD4|IIH / Condition, Cell_class and T cell subcluster | 3.68e-05 | 177 | 94 | 5 | fe73608c40701eca88b260aeb5c0640d7bee72ba | |
| ToppCell | facs-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.78e-05 | 178 | 94 | 5 | 9f59a9af232d77bb55603a7776dbf9749ea652f2 | |
| ToppCell | 368C-Myeloid-Dendritic-cDC_proliferating_1|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.89e-05 | 179 | 94 | 5 | ec69e1dd897414033ba5b007aa82655a79adca6c | |
| ToppCell | COVID-19-kidney-REN+Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 3.89e-05 | 179 | 94 | 5 | 342c1cc4444f51b8dcb30d3adc98285a25669c6e | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.99e-05 | 180 | 94 | 5 | 67c5068b660cd5e727a665cefe3bd5f8ae887221 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.10e-05 | 181 | 94 | 5 | 4d7793026373cbcf04b15c77f95f1025d07d4c00 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.10e-05 | 181 | 94 | 5 | 4ea02344e1996f264dd5e14f3b19c8782ce41699 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo-Cycling_T|Liver / Manually curated celltypes from each tissue | 4.20e-05 | 182 | 94 | 5 | 81557cdc88777f3bd4e1dd18a760b08fc29122ef | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.20e-05 | 182 | 94 | 5 | aa113a0d2c1d28bda24cbb1221afd21b5628dc6d | |
| ToppCell | droplet-Kidney-nan-3m-Endothelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.20e-05 | 182 | 94 | 5 | f4a5f1c3a04c0566eb96607dab7a0d9a5ebc3fd1 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue | 4.32e-05 | 183 | 94 | 5 | a48a6313f2f144586951cece97ec31f6d72361df | |
| ToppCell | B_cells-ISG-high_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 4.32e-05 | 183 | 94 | 5 | dc2b00e920efa1dcc2a6265cd1024e3249c9974f | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.32e-05 | 183 | 94 | 5 | c1297d8eddfc7132e84ceef14f01b6281f9d0f6a | |
| ToppCell | Control-Endothelial_cells-Pulmonary_venous_endothelial_cells|Control / group, cell type (main and fine annotations) | 4.32e-05 | 183 | 94 | 5 | 46be9f96755c7b65aeac061d95d15abeb6466034 | |
| ToppCell | 367C-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.32e-05 | 183 | 94 | 5 | a716b446c2bf5aa294b8f580aa845098fae76354 | |
| ToppCell | normal_Lung-Endothelial_cells-Tumor_ECs|normal_Lung / Location, Cell class and cell subclass | 4.43e-05 | 184 | 94 | 5 | 7ee98acda030366ac6cf3890a6d93fd0426712ed | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.43e-05 | 184 | 94 | 5 | f506d0ee48f39d6f59f19554217dfdf0987cc405 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.43e-05 | 184 | 94 | 5 | 8bcb1c4bc8ffef74338cdade926a94711de93c64 | |
| ToppCell | Endothelial-E|World / shred on cell class and cell subclass (v4) | 4.43e-05 | 184 | 94 | 5 | b4c561924c508536fd2112e91e32176b95fdf63a | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.43e-05 | 184 | 94 | 5 | d1e0e3b0eed2db8a5b7e3d6f81294667e4ba64e5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.54e-05 | 185 | 94 | 5 | 51dfe6ac7df8b330343b37e3bee71e5c65267189 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.54e-05 | 185 | 94 | 5 | a7dba7db79275884b2a93d8a16f2e0c739e71370 | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.54e-05 | 185 | 94 | 5 | f262b441ea3fe7f69dff33d5f171000371f3a3e5 | |
| ToppCell | Endothelial-A-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 4.54e-05 | 185 | 94 | 5 | dee0b7ba2f338f0979d2306aedf52ac35a36b60c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.54e-05 | 185 | 94 | 5 | a8c02cec3c414f3a0da9f2d6d28ce563b0030705 | |
| ToppCell | Control-Endothelial-Endothelial-Vein|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.66e-05 | 186 | 94 | 5 | 92092f11ecce22c14f244e42c499af0822977e6f | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-05 | 186 | 94 | 5 | 5302399825f213d105ac70b91366a4513b732838 | |
| ToppCell | droplet-Kidney-nan-3m-Endothelial-kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.78e-05 | 187 | 94 | 5 | d72012e94857606f39975cf672f6b8c2e0fe093e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.78e-05 | 187 | 94 | 5 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | 10x5'-Liver-Lymphocytic_NK-Cycling_NK|Liver / Manually curated celltypes from each tissue | 4.91e-05 | 188 | 94 | 5 | 5eb94e652a734c6f15c68a178e9d05f0febcf34c | |
| ToppCell | Endothelial-Endothelial-E|Endothelial / shred on cell class and cell subclass (v4) | 4.91e-05 | 188 | 94 | 5 | 2777eb7689b271c199021fe7d9db88ccebff14de | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.91e-05 | 188 | 94 | 5 | 319fbeca200ab998daf49fcaee0bfdb57bf7ee4b | |
| ToppCell | MatrixFB-Fibroblast-E_(Early_Fibroblastic_progenitor)|MatrixFB / shred on cell class and cell subclass (v4) | 4.91e-05 | 188 | 94 | 5 | b240ea20750ffb825cb5fe41d06c632233406ab6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.03e-05 | 189 | 94 | 5 | 7fbe855bfdb47d35e040b04a80fe4b729a3764e8 | |
| ToppCell | Control-Endothelial-VE_Peribronchial|World / Disease state, Lineage and Cell class | 5.03e-05 | 189 | 94 | 5 | c76d8af2e0aa4a83ee0c3439c894566fbf117dd3 | |
| ToppCell | droplet-Kidney-nan-21m-Endothelial-kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.03e-05 | 189 | 94 | 5 | 2ce330d8078833c05775c481e73770f9ee4a5c88 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.03e-05 | 189 | 94 | 5 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.03e-05 | 189 | 94 | 5 | 06b35abecd29f902cf251fcc1f6ad33db7ab08a2 | |
| ToppCell | Endothelial-A-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 5.03e-05 | 189 | 94 | 5 | 04b565855f58ca0f343904d04be657b66e109076 | |
| ToppCell | droplet-Kidney-nan-21m-Endothelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.03e-05 | 189 | 94 | 5 | 473c87036e04a058b4a5138438b7ba7e1e766799 | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.03e-05 | 189 | 94 | 5 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.16e-05 | 190 | 94 | 5 | 31de1727822e9818652946dfb962daee77ffad68 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-A_(Artery)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.16e-05 | 190 | 94 | 5 | ac2eb1e51459d187095152e0cd41ae54c1025c6f | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.16e-05 | 190 | 94 | 5 | 3b9abc25b17e7295356ded57ff2ca519fa9f2686 | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-Undetermined|normal_Pleural_Fluid / Location, Cell class and cell subclass | 5.16e-05 | 190 | 94 | 5 | 165c61443ff0c8efbdad3b052bb00f46d81c5203 | |
| ToppCell | Caecum-Dendritic_cell-cycling_DCs|Dendritic_cell / Region, Cell class and subclass | 5.16e-05 | 190 | 94 | 5 | 54463f6f1718f22704175bd034f134de3b55d2eb | |
| ToppCell | 343B-Endothelial_cells-Endothelial-A_(Artery)|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.16e-05 | 190 | 94 | 5 | 6010f16378f2d9cde37c7e7db6a7d9666edaddcc | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.16e-05 | 190 | 94 | 5 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 5.29e-05 | 191 | 94 | 5 | fad8eaa536001b911d05ae2b12150c2398cc6f88 | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.29e-05 | 191 | 94 | 5 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.29e-05 | 191 | 94 | 5 | fa380a8752de158974b2ae5e741573439719cc0d | |
| ToppCell | facs-Lung-3m-Endothelial-arterial_endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.29e-05 | 191 | 94 | 5 | 6e6b2cb390cc5cd0356924a2c36fbe5b5bd5966c | |
| ToppCell | Control-Endothelial-VE_Venous|Control / Disease state, Lineage and Cell class | 5.29e-05 | 191 | 94 | 5 | 617546cf4883dedf3323e03a53ba5adec334cf8e | |
| Drug | AC1N9ZLR | 2.77e-06 | 212 | 94 | 8 | CID004369063 | |
| Drug | Berberine chloride [633-65-8]; Down 200; 10.8uM; PC3; HT_HG-U133A | 1.71e-05 | 196 | 94 | 7 | 7143_DN | |
| Drug | Alexidine dihydrochloride [22573-93-9]; Down 200; 6.8uM; PC3; HT_HG-U133A | 1.71e-05 | 196 | 94 | 7 | 3699_DN | |
| Drug | Levopropoxyphene napsylate [5714-90-9]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 1.77e-05 | 197 | 94 | 7 | 5503_DN | |
| Drug | Betazole hydrochloride; Down 200; 27uM; MCF7; HT_HG-U133A | 1.83e-05 | 198 | 94 | 7 | 1690_DN | |
| Drug | Guanadrel sulfate [22195-34-2]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 1.95e-05 | 200 | 94 | 7 | 3438_DN | |
| Disease | ataxia telangiectasia (implicated_via_orthology) | 9.20e-06 | 2 | 90 | 2 | DOID:12704 (implicated_via_orthology) | |
| Disease | Benign neoplasm of stomach | 1.81e-05 | 17 | 90 | 3 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 1.81e-05 | 17 | 90 | 3 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 1.81e-05 | 17 | 90 | 3 | C0154060 | |
| Disease | Stomach Carcinoma | 3.51e-05 | 21 | 90 | 3 | C0699791 | |
| Disease | Neoplasm of uncertain or unknown behavior of ovary | 9.47e-05 | 29 | 90 | 3 | C0496920 | |
| Disease | Ovarian Carcinoma | 1.05e-04 | 30 | 90 | 3 | C0029925 | |
| Disease | Neurodevelopmental Disorders | 1.92e-04 | 93 | 90 | 4 | C1535926 | |
| Disease | blood phosphate measurement | 1.97e-04 | 174 | 90 | 5 | EFO_0010972 | |
| Disease | nasopharynx carcinoma (is_marker_for) | 3.10e-04 | 43 | 90 | 3 | DOID:9261 (is_marker_for) | |
| Disease | underweight body mass index status | 3.27e-04 | 9 | 90 | 2 | EFO_0005936 | |
| Disease | ovarian neoplasm | 7.68e-04 | 134 | 90 | 4 | C0919267 | |
| Disease | Lung cancer | 8.17e-04 | 14 | 90 | 2 | cv:C0242379 | |
| Disease | LUNG CANCER | 8.17e-04 | 14 | 90 | 2 | 211980 | |
| Disease | Neoplasm of lung | 8.17e-04 | 14 | 90 | 2 | cv:C0024121 | |
| Disease | Malignant neoplasm of ovary | 8.34e-04 | 137 | 90 | 4 | C1140680 | |
| Disease | Autistic Disorder | 1.24e-03 | 261 | 90 | 5 | C0004352 | |
| Disease | waist-hip ratio | CDCA2 PRUNE2 ZHX3 SEC16B PPP2R3A NRXN3 ZBTB7C AHNAK ETAA1 RERE MEIS2 | 1.26e-03 | 1226 | 90 | 11 | EFO_0004343 |
| Disease | thyroid peroxidase antibody measurement | 1.41e-03 | 72 | 90 | 3 | EFO_0005666 | |
| Disease | leukemia (implicated_via_orthology) | 1.52e-03 | 19 | 90 | 2 | DOID:1240 (implicated_via_orthology) | |
| Disease | Carcinoma of lung | 2.23e-03 | 23 | 90 | 2 | C0684249 | |
| Disease | Glioma | 2.42e-03 | 87 | 90 | 3 | C0017638 | |
| Disease | Pseudoaphakia | 2.43e-03 | 24 | 90 | 2 | C0524524 | |
| Disease | lateral orbital frontal cortex volume measurement | 2.43e-03 | 24 | 90 | 2 | EFO_0010312 | |
| Disease | Lens Opacities | 2.43e-03 | 24 | 90 | 2 | C1510497 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SSEQADFSLAQPDSP | 56 | Q6ZRG5 | |
| NLEEESNESGSPFDP | 881 | Q9H2P0 | |
| AADPVPSFDESSQDT | 806 | Q96QE3 | |
| FLPESFDGDPASNTA | 376 | P04626 | |
| PTFGPQDSFSEERSD | 146 | Q6UX73 | |
| PSFAPSSSVDGNNTD | 306 | Q6UB99 | |
| SAQGTPSEISFPNDD | 3056 | Q8IZF6 | |
| QDPINADSSSSFPNG | 1166 | O60242 | |
| SSESPSDNQAFQAPG | 61 | Q8TAB5 | |
| ASDDGAAPEDADSPQ | 916 | O94983 | |
| SSNPTGAEFDPEEDE | 186 | Q14738 | |
| NSFSDEREFSGPSTP | 5781 | Q09666 | |
| EDNLSFPTSDSDGPD | 1776 | Q9UKA4 | |
| FEDGENPPSSRSSES | 586 | Q5JWR5 | |
| GNDESESDFESDPPS | 736 | Q9NSY1 | |
| PRNPDYEESGESSSS | 81 | Q2NKX9 | |
| DSANDTEPDFAPGED | 191 | Q96B01 | |
| SPNGQDPEDGDSTAS | 236 | P50221 | |
| SFETEESDGQSGQPA | 371 | Q14207 | |
| PESGQENDATSPHFS | 16 | Q07108 | |
| GSDAESDSDDPSYAP | 536 | P0DP91 | |
| DDFSSPSITNEFGAP | 421 | A6NGU5 | |
| PFDAQTTGDGTEDPS | 521 | Q9NP74 | |
| SPFDIVGSSDNPDQN | 451 | P41743 | |
| FRENGSSSDNPSSPE | 356 | O75444 | |
| DSSNQEEEGPSTFPD | 86 | P43357 | |
| DSSNQEEEGPSTFPD | 86 | P43360 | |
| GSSNEEQEGPSTFPD | 86 | P43365 | |
| GTNSKGPPDFSSDEE | 56 | P42166 | |
| DNAPEPYDVSFGNSS | 286 | Q8N387 | |
| DFSANPEPASVASSN | 1021 | Q6UXM1 | |
| ASPTDTSNFDSFPED | 641 | Q13976 | |
| TSNFDSFPEDNDEPP | 646 | Q13976 | |
| IFFDSPAEDTQDSPA | 136 | Q9HAT1 | |
| DNSVASPGTGDDDDP | 256 | O14770 | |
| FDEDSSDALSPDQPA | 176 | Q9ULH7 | |
| GTNSKGPPDFSSDEE | 56 | P42167 | |
| TDEPASPSEFGNKSN | 1116 | Q06190 | |
| PQALNFSPEESDSTF | 586 | Q9NYZ3 | |
| SDSEAPEANPADGSD | 101 | Q7Z4V5 | |
| SSFSSPNDPDGQNDI | 91 | Q9NY74 | |
| PFSSTDANGDSNPFD | 406 | Q9UNF0 | |
| YPDSSVSDANEPGES | 861 | Q13315 | |
| PLFQHSPGDSSQEDS | 1866 | Q13535 | |
| DFNSPGGSSPVENSD | 936 | Q9Y2F5 | |
| EAPDGSQASSNSDPF | 556 | O75553 | |
| PLGPEDEDSFSNAES | 446 | P15391 | |
| PPGFRDSSDEEDSQS | 811 | Q14CM0 | |
| DSFDQRDPGTPNDDS | 106 | O00512 | |
| SDPSDDTKGFFDPNT | 2406 | P15924 | |
| GPSQDDSLQAFSSPS | 201 | Q96AQ9 | |
| NDNPPEFTASTFAGE | 386 | P55283 | |
| TNPFGETEDESFPEA | 471 | Q8NEU8 | |
| DLATVNSNPFDDPDA | 261 | Q8NDI1 | |
| PGHQTPSDLDQFSDS | 191 | Q8IV03 | |
| NSSSEADCPDPFANG | 776 | Q9Y4F3 | |
| DPENSQGPAAGSSDE | 956 | Q69YH5 | |
| DNADSENLSPFDSIP | 136 | Q5VV67 | |
| VFDDDSGNPSPESFL | 1051 | Q6ZRI0 | |
| NSGVGDFSQPDTSPD | 111 | Q14653 | |
| AFSLNDASDDTPPED | 16 | P57077 | |
| FNPKEADDETSDQPS | 566 | A6NKG5 | |
| PAGAPLADDSSDFQF | 1101 | Q93008 | |
| NQSDTDNFPDSKDSP | 61 | Q16650 | |
| SPADDFFPNSDLSEG | 516 | Q8WUY3 | |
| PAGDSVSQNDFPSEA | 1346 | A2VDJ0 | |
| TQSPETEASADSFPD | 651 | O15061 | |
| PDAPYDSDSGESQAS | 376 | Q1RMZ1 | |
| SFNGDAESVSDVPPS | 396 | Q14872 | |
| SGETFDSNLPPTDDE | 406 | Q9HDB5 | |
| GAPASQASDEEDAPA | 621 | O60331 | |
| PSNSEETCFVSDDGP | 291 | P98174 | |
| DFAQSGQDAVPESPS | 376 | O60285 | |
| DSPDPSSQSAAAGAN | 136 | Q2NL68 | |
| YEEDPASQPGTSQDA | 451 | O95785 | |
| PSPQDNESDSDSSAQ | 716 | Q9P2R6 | |
| SDKDEGDHPNNSFSP | 116 | P22692 | |
| SPEAADSASGAPNDF | 336 | Q13438 | |
| NPSPGSADGDKEFSD | 821 | P36956 | |
| TDALEFNPSANPEAS | 96 | A6NIR3 | |
| TSPVNSDFGFPSDSE | 21 | Q8N365 | |
| DSSPQSPDMEAFTDG | 796 | Q9NRU3 | |
| DPDPDSSNSGFDSSV | 246 | Q9UKZ1 | |
| PPDNAAGEFTDEDSG | 46 | Q6P3X8 | |
| SSPEFDSGPFSSQSD | 771 | O94827 | |
| PAFTEVDNPASFADS | 296 | Q5T4D3 | |
| SFSQAESNVDPEPDS | 1741 | Q96T58 | |
| DDNSLSQDFPGDESP | 306 | Q9H7N4 | |
| PSFSNSDNPAADSDS | 251 | Q8N394 | |
| ASPAGDEDSSDSPDS | 926 | Q96JE7 | |
| PSNSASEEESGKPFQ | 361 | Q17R98 | |
| GYESSSEDQPSTQPA | 291 | Q9H330 | |
| SDTPRDFPDSFQAGS | 201 | A1YPR0 | |
| SPQSPSSGAEAADED | 301 | Q8N1G0 | |
| PPSEDSNSQDSGEFA | 121 | Q8TF01 | |
| EGAAPQSPSFSGSED | 216 | Q13425 | |
| EASSEPFDTSSPQAG | 936 | Q9H4I2 | |
| GSPPEQALSEASFQD | 116 | Q15937 |